Ambicom (ABHI) 10-Q/A 16 Jun 15 2015 Q3 Quarterly report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Apr. 30, 2015	Jun. 15, 2015
Document Information [Line Items]
Entity Registrant Name	AMBICOM HOLDINGS, INC
Entity Central Index Key	1444310
Current Fiscal Year End Date	-24
Entity Filer Category	Smaller Reporting Company
Trading Symbol	ABHI
Entity Common Stock, Shares Outstanding		52,598,682
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	30-Apr-15
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2015

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Apr. 30, 2015	Jul. 31, 2014
Current assets:
Cash and cash equivalents	$56,649	$523,540
Accounts receivable, net of allowance for doubtful accounts of $270 and $26 as of April 30, 2015, and July 31, 2014, respectively	7,496	490
Inventory, net of allowance of $6,856 and $7,352 as of April 30, 2015, and July 31, 2014, respectively	24,691	64,120
Prepaid expenses and other current assets	37,573	9,839
Total current assets	126,409	597,989
Property and equipment, net	166,343	97,563
Deposit	20,695	20,695
Intangible assets, net	4,520,928	5,082,375
Total assets	4,834,375	5,798,622
Current liabilities:
Accounts payable and accrued liabilities	331,197	143,105
Accounts payable - other	0	0
Deferred revenue	41,730	1,980
Capital lease obligations - current portion	20,952	0
Note payable (Auto Loan) - current portion	15,688	15,735
Correctable debt net of debt discount - current portion	56,406	0
Total current liabilities	465,973	160,820
Capital lease obligations - net of current portion	61,811	0
Note payable (Auto Loan) - net of current portion	49,071	58,978
Convertible debt - net of debt discount - net of current portion	25,556	0
Derivative liabilities	579,021	0
Total liabilities	1,181,432	219,798
Commitments and contingencies (Note 5)
Convertible redeemable preferred stock, Series B, $0.008 par value 325,000 shares authorized; 262,475 shares issued and outstanding at April 30, 2015 and July 31, 2014. (Liquidation preference $2,600,000) - (Note 11)	262,475	262,475
Stockholders' equity:
Preferred stock, Series A, $0.001 par value; 10,000,000 shares authorized; 0 shares and 10,000,000 shares issued and outstanding at April 30, 2015 and July 31, 2014, respectively	0	10,000
Common stock, $0.008 par value; 125,000,000 shares authorized; 50,448,682 and 26,162,093 shares issued and outstanding at April 30, 2015 and July 31, 2014, respectively	403,587	209,297
Additional paid in capital	17,137,061	16,517,448
Accumulated deficit	-14,150,180	-11,420,396
Total stockholders' equity	3,390,468	5,316,349
Total liabilities and stockholders' equity	$4,834,375	$5,798,622

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Apr. 30, 2015	Jul. 31, 2014
Allowance for doubtful accounts (in dollars)	$270	$26
Inventory allowance (in dollars)	6,856	7,352
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	50,448,682	26,162,093
Common stock, shares outstanding	50,448,682	26,162,093
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	10,000,000
Preferred stock, shares outstanding	0	100,000,000
Redeemable Convertible Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share	$0.01	$0.01
Temporary Equity, Shares Authorized	325,000	325,000
Temporary Equity, Shares Issued	262,475	262,475
Temporary Equity, Shares Outstanding	262,475	262,475
Temporary Equity, Liquidation Preference	$2,600,000	$2,600,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Sales	$38,947	$476,684	$177,752	$1,719,120
Cost of sales	13,814	196,886	134,828	775,144
Gross profit	25,133	279,798	42,924	943,976
Operating Expenses
Selling and general expenses	367,627	192,906	1,223,425	603,537
Amortization of acquisition-related intangible	187,149	0	561,447	0
Research and development	120,812	28,480	357,837	85,580
Professional fees	90,579	38,470	394,476	214,389
Depreciation	11,054	6,488	28,870	17,675
Total operating expenses	777,221	266,344	2,566,055	921,181
Income (Loss) from operations	-752,088	13,454	-2,523,131	22,795
Other income (expense)
Other income (expense), net	-186,112	2,000	-141,725	2,000
Interest (expense), net	-54,559	-785	-63,328	-1,965
Net other income (expense)	-240,671	1,215	-205,053	35
Total income (loss) before income taxes	-992,759	14,669	-2,728,184	22,830
Income taxes	0	0	1,600	1,600
Net income (loss)	($992,759)	$14,669	($2,729,784)	$21,230
Net income (loss) per share - basic (in dollars per share)	($0.02)	$0.00	($0.07)	$0.00
Net income (loss) per share - diluted (in dollars per share)	($0.02)	$0.00	($0.07)	$0.00
Weighted average shares outstanding - basic (in shares)	48,968,504	11,382,377	39,817,640	11,099,146
Weighted average shares outstanding - diluted (in shares)	48,968,504	22,068,948	39,817,640	19,524,301

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
Cash flows from operating activities:
Net income (loss)	($2,729,784)	$21,230
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Amortization of intangibles	561,447	0
Change in fair value of derivative liabilities	139,819	0
Issuance of stock to advisors	234,600	47,000
Issuance of stock to employee	4,780	0
Issuance of stock to investor as a commitment fee	95,000	0
Stock based compensation	195,024	9,818
Issuance of stock to investor relation firm	87,500	50,000
Depreciation	28,870	17,675
Amortization of discount and issuance cost on convertible debt	47,581
Change in bad debt reserve	244	0
Issuance of Preferred A stock to Officer	0	2,950
Change in inventory allowance	-496	5,471
Decrease/ (increase) in operating assets and liabilities:
Accounts receivable	-7,250	-253,805
Inventory	39,924	11,706
Prepaid expenses and other current assets	-11,151	81,868
Accounts payable and accrued liabilities	188,091	32,148
Deferred revenue	39,750	-370,100
Net cash used in operating activities	-1,086,051	-344,039
Cash flows from investing activities:
Capital expenditures	0	-106,514
Net cash used in investing activities	0	-106,514
Cash flows from financing activities:
Proceeds from issuance of convertible debt	499,000	0
Proceeds from sale of common stock	145,000	25,000
Payment on capital Lease	-14,886	0
Proceeds/ (Payment) for note payable ( Auto Loan)	-9,954	77,894
Net cash provided by financing activities	619,160	102,894
Net decrease in cash and cash equivalents	-466,891	-347,659
Cash and cash equivalents, beginning of period	523,540	596,871
Cash and cash equivalents, end of period	56,649	249,212
Supplemental information:
Income taxes paid	0	0
Interest paid	8,769	1,965
Noncash investing and financing activities:
Fixed assets acquired pursuant to capital leases	97,650	0
Embedded derivative liabilities issued in connection with convertible debt	439,202	0
Issuance of common stock in connection with convertible debt	137,000	0
Conversion of preferred stock, series A, to common stock	10,000	0
6% dividend for preferred stock Series B holders issued in common stock	$126	$0

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (Series B Preferred Stock [Member])	9 Months Ended
	Apr. 30, 2015
Series B Preferred Stock [Member]
Preferred Stock, Dividend Rate, Percentage	6.00%

Organization_and_Principal_Act

Organization and Principal Activities	9 Months Ended
	Apr. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations [Text Block]	Note 1 – Organization and Principal Activities
	AmbiCom Holdings, Inc. (“AmbiCom Holdings” or the ‘Company”) was incorporated as Med Control, Inc. (“Med Control”) under the laws of the State of Nevada on July 1, 2008. Med Control was a development stage enterprise until January 15, 2010. All of Med Control’s activities prior to January 15, 2010 related to its organization, initial funding and share issuances.
	On January 15, 2010, the Company authorized an amendment its Articles of Incorporation (the “Amendment”) to change its name to AmbiCom Holdings, Inc., to increase the number of its authorized shares of capital stock from 75,000,000 to 1,050,000,000 shares of which 1,000,000,000 were designated common stock, par value $0.001 per share (the “Common Stock”) and 50,000,000 were designated preferred stock, par value $0.001 per share (the “Preferred Stock”) and to effect a forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock issued and outstanding immediately prior to filing of the amendment (the “Forward Split”).
	Also on January 15, 2010, the Company acquired AmbiCom Acquisition Corp. a privately owned Nevada corporation (“AmbiCom”), pursuant to an Agreement and Plan of Share Exchange (the “Exchange”). AmbiCom was organized under the laws of the State of Nevada on July 29, 2008. AmbiCom Holdings is a holding company whose operating company, AmbiCom, Inc., is a designer and developer of wireless products focusing on the wireless medical industry. AmbiCom’s wireless modules and devices are based on its innovative application software and Wi-Fi or Bluetooth technologies.
	Pursuant to the terms of the Exchange, the Company acquired AmbiCom from the AmbiCom former equity holders in exchange for an aggregate of 20,000,000 newly issued shares of Common Stock, 2,600,000 shares of Series B Preferred Stock, an option to purchase 5,500,000 shares of Common Stock and 2,350,000 shares of Series A Preferred Stock at the purchase price of $0.01 per share, and warrants to purchase 500,000 shares of Common Stock at the exercise price of $0.50 per share (collectively, the “Exchange Shares”). As a result of the Exchange, the AmbiCom equity holders surrendered all of their issued and outstanding capital stock of AmbiCom in consideration for the Exchange Shares and AmbiCom became a wholly-owned subsidiary of the Company.
	Simultaneously upon the Closing, the Company closed an offering (the “Offering”) of its Common Stock at a price of $0.40 per share for an aggregate of 1,250,000 shares of Common Stock for aggregate offering price of $500,000.
	For financial accounting purposes, the acquisition was a reverse acquisition of the Company by AmbiCom, under the purchase method of accounting, and was treated as a recapitalization with AmbiCom as the acquirer.  Upon consummation of the Exchange, the Company adopted the business plan of AmbiCom.
	On May 29, 2014, the Company acquired all of the assets of Veloxum Corporation, a Delaware corporation (“Veloxum”) in consideration for the issuance of 13,100,437 shares of the Company’s Common Stock. Following the Company’s acquisition of all of Veloxum’s assets, the Company has focused its operations as an optimizer of server’s infrastructure configuration settings.
	Details of the Company’s subsidiary as of April 30, 2015 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	Lagranger, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of optimizer of gaming infrastructure configuration settings.
		21-Apr-15
	Inter-company accounts and transactions have been eliminated in consolidation.

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Apr. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	Note 2 – Basis of Presentation
	The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The condensed balance sheet at July 31, 2014 has been derived from the audited financial statements at that date, but does not include all disclosures, including notes, required by GAAP for complete financial statements. In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the periods presented.
	The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements and, in the opinion of the Company’s management, reflect all adjustments of a normal recurring nature considered necessary to present fairly its financial position as of April 30, 2015 and results of its operations and cash flows for the three months and nine months ended April 30, 2015 and 2014. The interim results are not necessarily indicative of the results for any future interim period or for the entire year.
	Certain prior period amounts have been reclassified to conform to current period presentation. The accompanying condensed financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the year ended July 31, 2014 included in the Company’s Form 10-K.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Apr. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3 – Summary of Significant Accounting Policies
	The summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.
	a) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
	b) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, valuation of stock based compensation, valuation of convertible instruments and derivative liability, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
	c) Cash and Cash Equivalents - The Company considers all highly liquid investments and deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
	d) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $270 as of April 30, 2015 and $26 as of July 31, 2014, respectively.
	e) Inventory - Inventory is stated at the lower of cost or market on an average cost basis. Inventory allowances are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of April 30, 2015 and July 31, 2014, the value of the inventory allowance was $6,856 and $7,352 respectively, and the inventory was comprised of finished goods.
	f) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
	g) Intangible Assets – Developed technology and trade names were acquired as part of the Veloxum transaction in May 2014. Acquisition related intangibles are amortized over their estimated useful lives based on expected future benefit.
	The carrying amounts of the intangible assets as of April 30, 2015 and July 31, 2014 are as follows:
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
								July 31,						July 31,				Useful Life
		July 31, 2014		Additions		April 30, 2015		2014		Expense		April 30, 2015		2014		April 30, 2015		(Years)
	Developed technology	$	4,423,375	$	-	$	4,423,375	$	-133,203	$	-473,933	$	-607,136	$	4,290,172	$	3,816,239		7
	Trade names		816,800				816,800		-24,597		-87,514		-112,111		792,203		704,689		7
	Total intangible assets, net	$	5,240,175	$	-	$	5,240,175	$	-157,800	$	-561,447	$	-719,247	$	5,082,375	$	4,520,928
	Total amortization expense for intangible assets was $187,149 and $561,447 for the three months and nine months ended April 30, 2015, all of which was recorded in operating expenses. As of April 30, 2015, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows:
						Total
		Developed		Trade		intangible
	Year ending July 31,	technology		names		assets
	2015	$	157,978	$	29,172	$	187,150
	2016		631,911		116,686		748,597
	2017		631,911		116,686		748,597
	2018		631,911		116,686		748,597
	2019		631,911		116,686		748,597
	Thereafter		1,130,617		208,773		1,339,390
	Total intangible assets subject to amortization		3,816,239	$	704,689	$	4,520,928
	Developed technology and trade names are tested for impairment based on the guidelines in Accounting Standards Codification Topic 360-10-35, Impairment or Disposal of Long-Lived Assets
	A long-lived asset or asset group that is held and used should be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount for the long-live asset or asset group might not be recoverable. As a result, a company is not required to perform an impairment analysis if indicators of impairment are not present. Instead, a company would assess the need for an impairment write-down only if an indicator of impairment (also referred to as a triggering event) is present. As of April 30, 2015, no triggering events have occurred which would indicate that the acquired Veloxum developed technology and trade name values may not be recoverable. The strategy and plans that had been put in place at the original acquisition date were still effective and progressing as planned.
	h) Revenue Recognition - The Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For service and development projects, the company recognizes revenue upon the completion of the service and records costs incurred by the company for service and development under the project as cost of sales expenses.
	i) Research and Development Costs -Research and development costs are charged to operations as incurred. Research and development expenses consist primarily of compensation and related costs for personnel responsible for the research and development activities relating to new and existing products.
	j) Stock-Based Compensation - The Company accounts for its stock-based compensation expense based on the fair value of the stock-based awards that are ultimately expected to vest. The fair value of an employee stock option grant is estimated on the date of grant using the Black-Scholes option pricing model, and is recognized as expense on a straight-line basis over the employee’s requisite service period (generally the vesting period), net of estimated forfeitures. Forfeitures are estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from the prior estimates.
	The Company records the expense attributed to non-employee services paid with stock-based awards based on the estimated fair value of the awards determined using the Black-Scholes option pricing model. The measurement of stock-based compensation for non-employees is subject to re-measurement as the options vest, and the expense is recognized over the period during which services are received.
	k) Fair Value of Financial Instruments - The Company records its financial assets and liabilities at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting guidance for fair value establishes a three-level hierarchy for disclosure of fair value measurements, as follows:
	Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
	Level 2—Inputs (other than quoted market prices included in Level 1) that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the instrument’s anticipated life.
	Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The carrying values of certain financial assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities. The carrying value of the Company’s note payable (Auto loan) approximates its fair value as the terms of the borrowing are consistent with current market rates that the Company could obtain for debt with similar terms and maturities.
	The fair value measurement of the derivative liabilities for the conversion features associated with convertible debt are based on significant inputs that are unobservable and thus represent a Level 3 measurement. The Company’s estimated fair value of the derivative liabilities are calculated using the Black-Scholes valuation model. Key assumptions include the volatility of the Company’s stock, the Company’s stock price, expected dividend yield and risk-free interest rates. The Level 3 estimates are based, in part, on subjective assumptions.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial instruments as follows:
		Debt Conversion Feature
	Balance at August 1, 2014	$	-
	Issuance		439,202
	Change in fair value recorded in other income (expense), net		139,819
	Balance at April 30, 2015	$	579,021
	l) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk.
	The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of April 30, 2015 management does not believe it was exposed to any significant risk on cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors.
	Four customers accounted for 84% of revenue for the three months ended April 30, 2015 and two customers accounted for 93% of revenue for the three months ended April 30, 2014. One customer accounted for 17% of revenue for the nine months ended April 30, 2015 and three customers accounted for 85% of revenue for the nine months ended April 30, 2014.
	One vendor accounted for 100% of purchases for the three months ended April 30, 2015 and one vendor accounted for 97% of purchases for the three months ended April 30, 2014. One vendor accounted for 96% of purchases for the nine months ended April 30, 2015 and one vendor accounted for 95% of purchases for the nine months ended April 30, 2014.
	m) Convertible Instruments – The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging.”ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional (as that term is described in the implementation guidance to ASC 815).
	The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options.
	Derivative financial liabilities are initially recorded at fair value, with gains and losses arising from changes in fair value recognized in other income (expense), net in the consolidated statements of operations at each period end while such instruments are outstanding.
	The terms of the conversion features associated with the convertible debt do not explicitly limit the potential number of shares issuable upon conversion and accordingly could result in the Company’s obligation to deliver a potentially unlimited number of shares upon settlement. As such, share settlement is not considered to be within the control of the Company.
	Under ASC 815-40-35, the Company adopted a sequencing policy that reclassifies contracts, with the exception of stock options, from equity to assets or liabilities for those with the latest inception date first. Future issuance of securities will be evaluated as to reclassification as a liability under our sequencing policy of latest inception date.
	In accordance with the guidance under ASC 815-40-25, we have evaluated that we have a sufficient number of authorized and unissued shares as of April 30, 2015, to settle all existing commitments.

Liquidity_and_Managements_Plan

Liquidity and Management's Plan	9 Months Ended
	Apr. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Managements Plan [Text Block]	Note 4 -Liquidity and Management’s Plan
	As of April 30, 2015, the Company had cash and cash equivalents of $56,649 and an accumulated deficit of $14,150,180. The Company also incurred a net loss of $2,729,784 and had net cash used in operating activities of $1,086,051 for the nine months ended April 30, 2015. Given the Company’s negative cash flow from operations management anticipated its cash constraints and, therefore, took measures to meet its obligations.
	On May 21, 2015, the Company effectuated a Convertible Note Agreement with an investor for the purchase and sale of $43,000 of the Company’s original issue discount convertible note. The note, in the principal amount of $43,000, was issued on May 21, 2015 (Note 12- Subsequent Events).
	On April 24, 2015, the Company entered into a Series of transactions with Kodiak Capital Group, LLC. (“Kodiak”). On that date the Company entered into an Equity Purchase Agreement pursuant to which the Company may “put” to Kodiak up to $1,000,000 of shares of our Common Stock in amounts up to $25,000 per put upon effectiveness of a registration statement that may be filed for such purpose. The Company issued 500,000 shares of Common Stock as a commitment fee and executed a Registration Rights Agreement to register the Shares to be sold under the line. Also on that date, the Company entered into a Securities Purchase Agreement with Kodiak for the purchase and sale of original issue discount debentures for a borrowing amount of up to $500,000. The first note, a 15% Senior Secured Convertible Debenture, in the principal amount of $115,000 with proceeds of $100,000 was executed on April 24, 2015 and  is due on the first anniversary thereof. Principal and interest under the note is convertible at any time at the option of Kodiak into shares of the Company’s Common Stock at a conversion price equal to the lesser of $0.10 or 65% of the lowest closing bid price for the 30 trading days immediately prior to conversion. Thereafter, the Company shall sell and Kodiak shall purchase an additional debenture in the principal amount of $460,000 at the purchase price of $400,000, within 30 days following the effectiveness of a registration statement to be filed for the registration of the Shares underlying both debentures. On April 24, 2015, the Company issued Kodiak a 1% Convertible Redeemable Note in the amount of $50,000 whereby a pre-existing obligation to an unrelated third-party in the amount of $50,000 was assigned to Kodiak and exchanged for such note. Principal and interest under the note are convertible at any time at the option of Kodiak, into shares of Common Stock at the conversion price equal to 70% of the lowest closing bid price for the 30 trading days immediately prior to conversion.
	Management expects its new business for automated optimization of software applications will start generating revenue in the quarter ending July 31, 2015 and continue to grow. There can be no assurances that management will be able to successfully implement a long-term solution, and accordingly, the Company continues to explore debt and equity financing options. These conditions raise substantial doubt about the Company's ability to continue as a going concern through April 30, 2016.
	The Company believes in the viability of its strategy to increase revenue, cash flows, and profitability and in its ability to raise additional funds, and believes that the actions presently being taken by the Company will provide the Company with sufficient liquidity to continue to finance its operations.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Apr. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 5 –Commitments and Contingencies
	Office lease
	The Company leases its office and warehouse subject to an agreement that expires in May 2016. Rent expense was $13,419 for the three months ended April 30, 2015 and April 30, 2014. Rent expense was $40,256 for the nine months ended April 30, 2015 and April 30, 2014.
	Capital leases
	On October 31, 2014, the Company leased $93,294 of servers and network switches to increase production capacity for the OEM project with PC Driver Headquarters LP. The leases are payable in 60 monthly installments through fiscal year 2019. On March 31, 2015, the Company leased $4,356 of drivers to increase production capacity for the OEM project with PC Driver Headquarters LP. The leases are payable in 36 monthly installments through fiscal year 2018. The Company determined that the leases qualified as capital leases because the company will own the equipment at the end of the leasing term subject to a bargain purchase option. The Company allocated $20,952 to short-term capital lease obligations and $61,811 to long-term capital lease obligations at April 30, 2015.

Series_B_Convertible_Redeemabl

Series B Convertible Redeemable Preferred Stock (Redeemable Convertible Preferred Stock [Member], Servers And Network Switches [Member])	9 Months Ended
	Apr. 30, 2015
Redeemable Convertible Preferred Stock [Member] | Servers And Network Switches [Member]
Series B Convertible Redeemable Preferred Stock	Note 6–Series B Convertible Redeemable Preferred Stock
	In September 2011, the Company amended and restated its Articles of Incorporation. Before the amendment, there were 2,600,000 shares of Series B Convertible Preferred Stock authorized at $0.001 par value per share. After the amendment, the authorized number of shares of Series B Convertible Preferred Stock was changed to 325,000 at $0.008 par value per share.
	As of April 30, 2015 and July 31, 2014, there were 262,475 shares of Series B Convertible Preferred Stock outstanding.
	The Series B accrues annual dividends at the rate of 6% per year in shares of Common Stock at the dividend conversion rate of $1.00.  The Series B, together with any unpaid dividends, is convertible at any time into shares of the Company’s common stock at the conversion rate of eight shares of Common Stock for each share of Series B converted.  Following the second anniversary of the Exchange, the Series B, together with any unpaid dividends, shall be convertible into Common Stock at the conversion price divided by the greater of forty cents ($0.40) or seventy percent (70%) of the daily volume weighted average price of the Common Stock for the twenty trading days immediately prior to the conversion.  The Series B is redeemable by the Company, at any time prior to December 31, 2015, in cash at the redemption rate of $1.00 per share of Series B plus any accrued and unpaid dividends. On December 31, 2015, all outstanding shares of Series B shall be redeemed by the Company at a per share redemption price equal to $1.00 per share of Series B plus an amount of Common Stock equal to the amount of the accrued and unpaid dividend thereon.  The Series B has a liquidation preference of $2,600,000 and has priority over the Series A Preferred Stock and the Common Stock.  The Series B votes on an “as converted” basis.

Shareholders_Equity

Shareholders' Equity	9 Months Ended
	Apr. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note7 – Shareholders’ Equity
	Preferred Stock
	The Company's Amended Articles of Incorporation authorizes the issuance of 50,000,000 shares of Preferred Stock, subject to any limitations prescribed by law, without further vote or action by the stockholders, to issue from time to time shares of preferred stock in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Company's board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences, conversion rights and preemptive rights.
	Series A Convertible Preferred Stock
	The Company has authorized a total of 10,000,000 shares of Series A Convertible Preferred Stock (the “Series A”).  The Series A is convertible at any time into shares of the Company’s common stock at the conversion rate of two shares of Common Stock per each share of Series A converted.  The Series A is treated on an “as converted” basis for both voting and liquidation rights. On November 20, 2014, the CEO of the Company converted 10,000,000 shares of preferred Series A to 20,000,000 shares of common stock. There are no shares of Series A preferred stock outstanding as of April 30, 2015.
	Options
	As of April 30, 2015, there were options issued and outstanding for the purchase of 1,800,000 shares of common stock under the 2010 Equity Incentive Plan and 2,500,000 shares of common stock under the 2014 Equity Incentive Plan.
	2010 Equity Incentive Plan
	On January 15, 2010, the Board and Stockholders approved and adopted the 2010 Equity Incentive Plan (the “2010 Plan”).
	The 2010 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2010 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of common stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2010 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2010 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	No options were granted under the 2010 Plan during the three and nine months ended April 30, 2015 and April 30, 2014
	At April 30, 2015, 477,778 options remain available for future grant under the 2010 Plan.
	As of April 30, 2015, there were options outstanding under the 2010 Plan to purchase 200,000 shares of common stock at a purchase price of $0.20 per share, 250,000 shares of common stock at a purchase price of $0.09 per share, 75,000 shares of common stock at a purchase price of $0.03 per share, 275,000 shares of common stock at a purchase price of $0.16 per share and 1,000,000 shares of common stock at a purchase price of $0.24 per share. No options have been exercised since the Plan was created.
	The Company recognized a non-cash stock compensation expense of $30,477 and $92,125 for the three months and the nine months ended April 30, 2015, respectively in connection with options issued under the 2010 Plan.
	2014 Equity Incentive Plan
	On June 2, 2014, the Board and Stockholders approved and adopted the 2014 Equity Incentive Plan (the “2014 Plan”).
	The 2014 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2014 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of common stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2014 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2014 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	The Board reserved a total of 10,000,000 shares of Common Stock for issuance under the 2014 Plan. If an incentive award granted under the 2014 Plan expires, terminates, is unexercised, or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the Plan.
	The number of shares subject to the 2014 Plan, any number of shares subject to any numerical limit in the 2014 Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in the Company outstanding Common Stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction.
	On August 11, 2014, 1,750,000 options were granted to two employees at an exercise price of $0.24 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.48%; volatility of 49%; expected life of 6.5 years; and zero dividend yield; the Company recognized a non-cash stock compensation charge of $27,129 and $81,387 for the three months and the nine months ended April 30, 2015 respectively in connection with the issuance and vesting of these options.
	On September 5, 2014, 750,000 options were granted to one employee at an exercise price of $0.24 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.48%; volatility of 43%; expected life of 6.5 years; and zero dividend yield, the Company recognized a non-cash stock compensation charge of $8,067 and $21,512 for the three months and the nine months ended April 30, 2015, respectively in connection with the issuance and vesting of these options.
	As of April 30, 2015, there were options outstanding under the 2014 Plan to purchase 2,500,000 shares of Common Stock at a purchase price of $0.24 per share. No options have been exercised since the Plan was created.
	All non-cash stock compensation expenses for the nine months ended April 30, 2015 and 2014 were allocated to selling and general expenses.
	Common Stock
	In September 2011, the Company amended and restated its Articles of Incorporation to effectuate a 1 for 8 reverse stock split by decreasing the authorized shares for issuance from 1,000,000,000 shares of common stock, $0.001 par value per share to 125,000,000 shares of common stock, $0.008 par value per share. On June 8, 2015, a majority of the Company’s shareholders, ant its Board of Directors, approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of Common Stock to 200,000,000. There were 50,448,682 and 26,162,093 shares of common stock outstanding as of April 30, 2015 and July 31, 2014, respectively.
	During the nine months ended April 30, 2015, the Company issued the following shares of common stock:
	The CEO of the Company converted his 10,000,000 shares of preferred Series A stock to 20,000,000 shares of common stock.
	The Company issued 15,760 shares of common stock to its preferred Series B shareholders for accrued annual dividends at the rate of 6% per year.
	The Company issued a total of 1,858,118 shares of common stock to service providers in exchange for services provided.
	The Company issued a total of 1,475,953 shares of common stock to an investor, Kodiak Capital Group, LLC, pursuant to an investment agreement entered into in October, 2011.
	The Company issued 236,758 shares of common stock in connection with employee and consultant.
	The Company issued 200,000 shares of common stock in connection with convertible debt (Note 10- Convertible debt).
	The Company issued 500,000 shares of common stock as a commitment fee for entering into a new investment agreement with Kodiak on April 20, 2015.
	Kodiak Capital Group LLC Investment Agreement
	On October 31, 2011, we entered into an Investment Agreement and a Registration Rights Agreement with Kodiak Capital Group, LLC (the “Investor”) to purchase up to $1,000,000 of the Company’s Common Stock. In accordance with these Equity Line Transaction agreements, the Company filed a registration statement on Form S-1, which was declared effective on January 25, 2013. The Investment Agreement allows the Company to sell Common Stock in increments of $25,000 at a per share purchase price equal to 80% of the volume weighted average price of the Common Stock over five consecutive trading days. The agreements provide for the Company to exercise put options that obligate the Investor to purchase common stock shares valued at $25,000 per each put option.
	Pursuant to the agreement, the Company issued the following common stock to the Investor, each in exchange for a $25,000 investment: 120,193 shares on March 25, 2014; 208,333 shares on May 12, 2014; 100,806 shares on May 27, 2014; 148,810 shares on September 23, 2014; 168,919 shares on October 3, 2014; 219,491 shares on October 13, 2014; 223,215 shares on October 22, 2014; and 215,518 shares on November 4, 2014.
	On April 20, 2015, we entered into a new Investment Agreement and a Registration Rights Agreement with the same investor to purchase up to $1,000,000 of the Company’s Common Stock. The Investment Agreement allows the Company to sell Common Stock in increments of $25,000 at a per share purchase price equal to 80% of the volume weighted average price of the Common Stock over five consecutive trading days. The agreements provide for the Company to exercise put options that obligate the Investor to purchase common stock shares valued at $25,000 per each put option. The Company issued 500,000 shares of common stock to Kodiak as a commitment fee on the date of the transaction and recorded $95,000 as other expense on the statement of operations to account for the value of the issued shares based on the trading price of the Company’s stock on the issuance date.
	Pursuant to the 2015 agreement with the investor, the Company issued 500,000 shares on April 24, 2015 in exchange for a $25,000 investment.

Property_and_Equipment

Property and Equipment	9 Months Ended
	Apr. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 8 – Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets: furniture and fixtures –seven years; machinery and equipment –five years; software – five years; leasehold improvements –the life of the current facility lease. Major additions and betterments are capitalized and repairs and maintenance are charged to operations in the period incurred. Depreciation expense for the three months and the nine months ended April 30, 2015 and 2014 was $11,054 and $6,488, $28,870 and $17,675, respectively. The assets under capital leases as of April 30, 2015 and July 31, 2014 were $97,649 and $0, respectively. Accumulated depreciation related to assets under capital leases as of these dates was $9,914 and $0, respectively.
		April 30, 2015		July 31, 2014
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		125,190		27,540
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		105,278
			623,504		525,854
	Accumulated depreciation		-457,161		-428,291
	Property and equipment, net	$	166,343	$	97,563

Note_Payable_Auto_loan

Note Payable (Auto loan)	9 Months Ended
	Apr. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 9 - Note Payable (Auto loan)
	The note payable (auto loan) consists of the following as of April 30, 2015 and July 31, 2014:
	Note Payable Consists of the Following at:
		April 30, 2015		July 31, 2014
	Note payable (Auto Loan)		64,759	$	74,713
	Less current portion		15,688		15,735
	Long-term note payable	$	49,071	$	58,978
	The note payable, secured by an automobile, bears interest at 3.99% per annum and has a maturity date of October 9, 2019.

Convertible_Debt_and_Derivativ

Convertible Debt and Derivative Liability	9 Months Ended
	Apr. 30, 2015
Debt Disclosure [Abstract]
Convertible Debt and Derivative Liability [Text Block]	Note 10 – Convertible Debt and Derivative Liability
	On December 18, 2014, the Company effectuated a convertible Note Agreement with an investor for the purchase and sale of up to $285,000 of the Company’s original issue discount convertible debentures with a term of 3 years. The first debenture, in the principal amount of $160,000, was issued on December 18, 2014.
	In connection with the agreement, the Company provided the lender with 200,000 shares of common stock. The Company used the trading price of its common stock on December 18, 2014 to determine the value of the common stock. The Company recorded a debt discount of $42,000 attributed to the issuance of the common stock.
	Per the agreement, the holder may convert the notes into common stock at 70% of the lowest trading price in a 20 day trading window prior to the conversion. The Company has determined that the right to convert the notes at a discount represents an embedded derivative liability that met the criteria for bifurcation under ASC 815 “Derivative and Hedging” which generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. The fair value of the derivative liability was calculated using a Black Scholes model on December 18, 2014 and remeasured at April 30, 2015. The Company recorded a debt discount for the fair value of the derivative liability of $102,000 on the issuance date. The debt discount attributed to the convertible note, the issuance of the common stock, and the derivative liability is being amortized over the term of the note of 3 years and recorded as interest expense in the statements of operations. As of April 30, 2015, the Company determined the fair value of the derivative liability has increased to $191,122 and accordingly recorded $89,122 to capture the change in fair value as other expense in the statements of operations.
	On February 20, 2015, the Company effectuated a convertible Note Agreement with an investor for the purchase and sale of up to $66,667 of the Company’s original issue discount convertible notes with a term of 2 years.
	Per the agreement, the holder may convert the notes into common stock at the lesser of $0.15 per share or 60% of the lowest trading price in a 25 day trading window prior to the conversion. The note does not bear interest if repaid within 90 day of the borrowing date while a 12% one-time interest fee will be charged on the 91st day if the note is still outstanding. The Company has determined that the right to convert the notes at a discount represents an embedded derivative liability that met the criteria for bifurcation under ASC 815 “Derivative and Hedging” which generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. The fair value of the derivative liability was calculated using a Black Scholes model on February 20, 2015 and remeasured at April 30, 2015. The Company recorded a debt discount for the fair value of the derivative liability of $60,667 on the issuance date. The debt discount attributed to the convertible note, and the derivative liability is being amortized over the term of the note of 2 years and recorded as interest expense in the statements of operations. As of April 30, 2015, the Company determined the fair value of the derivative liability has increased to $80,355 and accordingly recorded $20,355 to capture the change in fair value as other expense in the statements of operations.
	On March 4, 2015, the Company effectuated a convertible Note Agreement with an investor for a principal balance of $100,000 of convertible note with a term of 1 year.
	Per the agreement, the holder may convert the notes into common stock at the 60% of the lowest trading price in a 15 day trading window prior to the conversion. The debt accrues interest at a rate of 8% per annum, payable in common stock at the conversion rate. The Company has determined that the right to convert the notes at a discount represents an embedded derivative liability that met the criteria for bifurcation under ASC 815 “Derivative and Hedging” which generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. The fair value of the derivative liability was calculated using a Black Scholes model on March 4, 2015 and remeasured at April 30, 2015. The Company recorded a debt discount for the fair value of the derivative liability of $89,672 on the issuance date. The debt discount attributed to the derivative liability is being amortized over the term of the note of 1 year and recorded as interest expense in the statements of operations. As of April 30, 2015, the Company determined the fair value of the derivative liability has declined to $86,562 and accordingly recorded $3,110 to capture the change in fair value as other income in the statements of operations.
	On April 1, 2015, the Company effectuated a convertible promissory note with an investor for a total principal balance of $64,000 of with a term of 1 year.
	Per the agreement, the holder may convert the note into common stock at 61% of the lowest 3 trading prices in a 10 day trading window prior to the conversion after 180 days. The note accrues interest at a rate of 8% per annum. The Company has determined that the right to convert the note at a discount represents an embedded derivative liability that met the criteria for bifurcation under ASC 815 “Derivative and Hedging” which generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. The fair value of the derivative liability was calculated using a Black Scholes model on April 1, 2015 and remeasured at April 30, 2015. The Company recorded a debt discount for the fair value of the derivative liability of $60,000 on the issuance date. The debt discount attributed to the derivative liability is being amortized over the term of the note of 1 year and recorded as interest expense in the statements of operations. As of April 30, 2015, the Company determined the fair value has declined to $54,619 and accordingly recorded $1,339 to capture the change in fair value as other income in the statements of operations.
	On April 24, 2015, the Company effectuated a convertible Note Agreement with an investor for a total principal of up to $115,000 with a term of 1 year. The debenture, in the principal amount of $115,000, was issued on April 24, 2015.
	Per the agreement, the holder may convert the note into common stock at the lesser of $0.10 or 65% of the lowest trading price in a 30 day trading window preceding the date of conversion. The note accrues interest at a rate of 15% per annum. The Company has determined that the right to convert the note at a discount represents an embedded derivative liability that met the criteria for bifurcation under ASC 815 “Derivative and Hedging” which generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. The fair value of the derivative liability was calculated using a Black Scholes model on April 24, 2015 and remeasured at April 30, 2015. The Company recorded a debt discount for the fair value of the derivative liability of $100,000 on the issuance date. The debt discount attributed to the convertible note and the derivative liability is being amortized over the term of the note of 1 year and recorded as interest expense in the statements of operations. As of April 30, 2015, the Company determined the fair value has increased to $135,388 and accordingly recorded $35,388 to capture the change in fair value as other expense in the statements of operations.
	On April 24, 2015, the Company effectuated a convertible note agreement with an investor for the purchase and sale of $50,000 of the Company’s original issue discount convertible note with a term of 8 months.
	Per the agreement, the holder may convert the notes into common stock at 70% of the lowest trading price in a 30 day trading window prior to the conversion. The note accrues an interest of 1% per annum. The Company has determined that the right to convert the notes at a discount represents an embedded derivative liability that met the criteria for bifurcation under ASC 815 “Derivative and Hedging” which generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. The fair value of the derivative liability was calculated using a Black Scholes model on April 24, 2015 and remeasured at April 30, 2015. The Company recorded a debt discount for the fair value of the derivative liability of $31,572 on the issuance date. The debt discount attributed to the convertible note, and the derivative liability is being amortized over the term of the note of 7 months and recorded as interest expense in the statements of operations. As of April 30, 2015, the Company determined the fair value of the derivative liability has declined to $30,975 and accordingly recorded $597 to capture the change in fair value as other income in the statements of operations.
	As of April 30, 2015, amounts outstanding under the Company’s debentures were as follows:
	Principal balance	$	555,667
	Debt discount		-473,705
	Net carrying value of debt	$	81,962
	Less current portion		56,406
	Long-term net carrying value of debt	$	25,556

Revision_of_Prior_Period_Amoun

Revision of Prior Period Amounts	9 Months Ended
	Apr. 30, 2015
Accounting Changes and Error Corrections [Abstract]
Accounting Changes and Error Corrections [Text Block]	Note 11 – Revision of Prior Period Amounts
	It was determined during the preparation of the interim financial statements for the three months ended April 30, 2015, that adjustments were required relating to periods preceding August 1, 2014. These adjustments resulted from the Company’s re-evaluation of the accounting treatment of the Series B Convertible Redeemable Preferred Stock (the “Series B”), which was originally recorded in stockholders’ equity upon issuance. Management determined that the Series B meets the definition of a temporary equity instrument in accordance with ASC Topic 480-10-S99“Accounting for Redeemable Equity Instruments”. Accordingly, the Company determined that the Series B should be classified as temporary equity and recorded at its redemption value.
	Management has evaluated the effect of this prior period adjustment and determined that it was immaterial to each of the reporting periods affected and, therefore, amendment of previously filed reports was not required. In accordance with guidelines issued in SEC Staff Accounting Bulletin, we have recorded adjustments to correct and reclassify the current year’s beginning Convertible Redeemable Preferred Stock Series B and Additional paid in capital amounts to correct these immaterial prior period errors. We also plan to revise in future filings of our 10-Q and 10-K, the previously reported quarterly and annual financial statements during the year ended July 31, 2014 for these immaterial amounts.
	The following table sets forth the revised prior period balances reported in our comparative financial statements:
		Previously
		reported		Adjustment		Revised
	Balance sheet items at July 31, 2014:
	Preferred Stock, Series B		2,100		260,375		262,475
	Additional paid in capital		16,777,826		-260,375		16,517,448
	Total stockholders’ equity		5,578,824		-262,475		5,316,349

Subsequent_Events

Subsequent Events	9 Months Ended
	Apr. 30, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 12 – Subsequent Events
	Management of the Company performed an evaluation of all subsequent events that occurred as of the date these financial statements were issued to determine if they must be reported. Management of the Company has determined that the following subsequent events are required to be disclosed:
	On May 21, 2015, the Company effectuated a Convertible Note Agreement (the “Agreement”) with an investor (the “Investor”) a total principal of $43,000. The Note bears interest at a rate of 8% per annum and is convertible into shares of common stock at a conversion price equal 61% of the lowest trade price in the 10 trading days prior to the conversion. The principal and accrued interest balances are due on February 26,2016.
	On June 8, 2015, holders of a majority of the Company’s issued and outstanding common stock and its Board of Directors approved an amendment to its Articles of Incorporation increasing the Company’s Authorized Capital to 250,000,000 shares, of which 200,000,000 will be common stock, par value $0.008 per share, and 50,000,000 shares will be preferred stock, par value $0.001 per share.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Apr. 30, 2015
Accounting Policies [Abstract]
Segment Reporting, Policy [Policy Text Block]	a) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
Use of Estimates, Policy [Policy Text Block]	b) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, valuation of stock based compensation, valuation of convertible instruments and derivative liability, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
Cash and Cash Equivalents, Policy [Policy Text Block]	c) Cash and Cash Equivalents - The Company considers all highly liquid investments and deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
Allowance for Doubtful Accounts [Policy Text Block]	d) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $270 as of April 30, 2015 and $26 as of July 31, 2014, respectively.
Inventory, Policy [Policy Text Block]	e) Inventory - Inventory is stated at the lower of cost or market on an average cost basis. Inventory allowances are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of April 30, 2015 and July 31, 2014, the value of the inventory allowance was $6,856 and $7,352 respectively, and the inventory was comprised of finished goods.
Income Tax, Policy [Policy Text Block]	f) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	g) Intangible Assets – Developed technology and trade names were acquired as part of the Veloxum transaction in May 2014. Acquisition related intangibles are amortized over their estimated useful lives based on expected future benefit.
	The carrying amounts of the intangible assets as of April 30, 2015 and July 31, 2014 are as follows:
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
								July 31,						July 31,				Useful Life
		July 31, 2014		Additions		April 30, 2015		2014		Expense		April 30, 2015		2014		April 30, 2015		(Years)
	Developed technology	$	4,423,375	$	-	$	4,423,375	$	-133,203	$	-473,933	$	-607,136	$	4,290,172	$	3,816,239		7
	Trade names		816,800				816,800		-24,597		-87,514		-112,111		792,203		704,689		7
	Total intangible assets, net	$	5,240,175	$	-	$	5,240,175	$	-157,800	$	-561,447	$	-719,247	$	5,082,375	$	4,520,928
	Total amortization expense for intangible assets was $187,149 and $561,447 for the three months and nine months ended April 30, 2015, all of which was recorded in operating expenses. As of April 30, 2015, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows:
						Total
		Developed		Trade		intangible
	Year ending July 31,	technology		names		assets
	2015	$	157,978	$	29,172	$	187,150
	2016		631,911		116,686		748,597
	2017		631,911		116,686		748,597
	2018		631,911		116,686		748,597
	2019		631,911		116,686		748,597
	Thereafter		1,130,617		208,773		1,339,390
	Total intangible assets subject to amortization		3,816,239	$	704,689	$	4,520,928
	Developed technology and trade names are tested for impairment based on the guidelines in Accounting Standards Codification Topic 360-10-35, Impairment or Disposal of Long-Lived Assets
	A long-lived asset or asset group that is held and used should be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount for the long-live asset or asset group might not be recoverable. As a result, a company is not required to perform an impairment analysis if indicators of impairment are not present. Instead, a company would assess the need for an impairment write-down only if an indicator of impairment (also referred to as a triggering event) is present. As of April 30, 2015, no triggering events have occurred which would indicate that the acquired Veloxum developed technology and trade name values may not be recoverable. The strategy and plans that had been put in place at the original acquisition date were still effective and progressing as planned.
Revenue Recognition, Policy [Policy Text Block]	h) Revenue Recognition - The Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For service and development projects, the company recognizes revenue upon the completion of the service and records costs incurred by the company for service and development under the project as cost of sales expenses.
Research and Development Expense, Policy [Policy Text Block]	i) Research and Development Costs -Research and development costs are charged to operations as incurred. Research and development expenses consist primarily of compensation and related costs for personnel responsible for the research and development activities relating to new and existing products.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	j) Stock-Based Compensation - The Company accounts for its stock-based compensation expense based on the fair value of the stock-based awards that are ultimately expected to vest. The fair value of an employee stock option grant is estimated on the date of grant using the Black-Scholes option pricing model, and is recognized as expense on a straight-line basis over the employee’s requisite service period (generally the vesting period), net of estimated forfeitures. Forfeitures are estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from the prior estimates.
	The Company records the expense attributed to non-employee services paid with stock-based awards based on the estimated fair value of the awards determined using the Black-Scholes option pricing model. The measurement of stock-based compensation for non-employees is subject to re-measurement as the options vest, and the expense is recognized over the period during which services are received.
Fair Value of Financial Instruments, Policy [Policy Text Block]	k) Fair Value of Financial Instruments - The Company records its financial assets and liabilities at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting guidance for fair value establishes a three-level hierarchy for disclosure of fair value measurements, as follows:
	Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
	Level 2—Inputs (other than quoted market prices included in Level 1) that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the instrument’s anticipated life.
	Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The carrying values of certain financial assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities. The carrying value of the Company’s note payable (Auto loan) approximates its fair value as the terms of the borrowing are consistent with current market rates that the Company could obtain for debt with similar terms and maturities.
	The fair value measurement of the derivative liabilities for the conversion features associated with convertible debt are based on significant inputs that are unobservable and thus represent a Level 3 measurement. The Company’s estimated fair value of the derivative liabilities are calculated using the Black-Scholes valuation model. Key assumptions include the volatility of the Company’s stock, the Company’s stock price, expected dividend yield and risk-free interest rates. The Level 3 estimates are based, in part, on subjective assumptions.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial instruments as follows:
		Debt Conversion Feature
	Balance at August 1, 2014	$	-
	Issuance		439,202
	Change in fair value recorded in other income (expense), net		139,819
	Balance at April 30, 2015	$	579,021
Concentration [Policy Text Block]	l) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk.
	The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of April 30, 2015 management does not believe it was exposed to any significant risk on cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors.
	Four customers accounted for 84% of revenue for the three months ended April 30, 2015 and two customers accounted for 93% of revenue for the three months ended April 30, 2014. One customer accounted for 17% of revenue for the nine months ended April 30, 2015 and three customers accounted for 85% of revenue for the nine months ended April 30, 2014.
	One vendor accounted for 100% of purchases for the three months ended April 30, 2015 and one vendor accounted for 97% of purchases for the three months ended April 30, 2014. One vendor accounted for 96% of purchases for the nine months ended April 30, 2015 and one vendor accounted for 95% of purchases for the nine months ended April 30, 2014.
Derivatives, Policy [Policy Text Block]	m) Convertible Instruments – The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging.”ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,(b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional (as that term is described in the implementation guidance to ASC 815).
	The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options.
	Derivative financial liabilities are initially recorded at fair value, with gains and losses arising from changes in fair value recognized in other income (expense), net in the consolidated statements of operations at each period end while such instruments are outstanding.
	The terms of the conversion features associated with the convertible debt do not explicitly limit the potential number of shares issuable upon conversion and accordingly could result in the Company’s obligation to deliver a potentially unlimited number of shares upon settlement. As such, share settlement is not considered to be within the control of the Company.
	Under ASC 815-40-35, the Company adopted a sequencing policy that reclassifies contracts, with the exception of stock options, from equity to assets or liabilities for those with the latest inception date first. Future issuance of securities will be evaluated as to reclassification as a liability under our sequencing policy of latest inception date.
	In accordance with the guidance under ASC 815-40-25, we have evaluated that we have a sufficient number of authorized and unissued shares as of April 30, 2015, to settle all existing commitments.

Organization_and_Principal_Act1

Organization and Principal Activities (Tables)	9 Months Ended
	Apr. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Subsidiaries Establishment and Incorporation [Table Text Block]	Details of the Company’s subsidiary as of April 30, 2015 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	Lagranger, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of optimizer of gaming infrastructure configuration settings.
		21-Apr-15

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Apr. 30, 2015
Accounting Policies [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	The carrying amounts of the intangible assets as of April 30, 2015 and July 31, 2014 are as follows:
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
								July 31,						July 31,				Useful Life
		July 31, 2014		Additions		April 30, 2015		2014		Expense		April 30, 2015		2014		April 30, 2015		(Years)
	Developed technology	$	4,423,375	$	-	$	4,423,375	$	-133,203	$	-473,933	$	-607,136	$	4,290,172	$	3,816,239		7
	Trade names		816,800				816,800		-24,597		-87,514		-112,111		792,203		704,689		7
	Total intangible assets, net	$	5,240,175	$	-	$	5,240,175	$	-157,800	$	-561,447	$	-719,247	$	5,082,375	$	4,520,928
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	As of April 30, 2015, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows:
						Total
		Developed		Trade		intangible
	Year ending July 31,	technology		names		assets
	2015	$	157,978	$	29,172	$	187,150
	2016		631,911		116,686		748,597
	2017		631,911		116,686		748,597
	2018		631,911		116,686		748,597
	2019		631,911		116,686		748,597
	Thereafter		1,130,617		208,773		1,339,390
	Total intangible assets subject to amortization		3,816,239	$	704,689	$	4,520,928
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial instruments as follows:
		Debt Conversion Feature
	Balance at August 1, 2014	$	-
	Issuance		439,202
	Change in fair value recorded in other income (expense), net		139,819
	Balance at April 30, 2015	$	579,021

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended
	Apr. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		April 30, 2015		July 31, 2014
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		125,190		27,540
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		105,278
			623,504		525,854
	Accumulated depreciation		-457,161		-428,291
	Property and equipment, net	$	166,343	$	97,563

Note_Payable_Auto_loan_Tables

Note Payable (Auto loan) (Tables)	9 Months Ended
	Apr. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Note Payable Consists of the Following at:
		April 30, 2015		July 31, 2014
	Note payable (Auto Loan)		64,759	$	74,713
	Less current portion		15,688		15,735
	Long-term note payable	$	49,071	$	58,978

Convertible_Debt_and_Derivativ1

Convertible Debt and Derivative Liability (Tables)	9 Months Ended
	Apr. 30, 2015
Debt Disclosure [Abstract]
Convertible Debt [Table Text Block]	As of April 30, 2015, amounts outstanding under the Company’s debentures were as follows:
	Principal balance	$	555,667
	Debt discount		-473,705
	Net carrying value of debt	$	81,962
	Less current portion		56,406
	Long-term net carrying value of debt	$	25,556

Revision_of_Prior_Period_Amoun1

Revision of Prior Period Amounts (Tables)	9 Months Ended
	Apr. 30, 2015
Accounting Changes and Error Corrections [Abstract]
Schedule of Quantifying Prior Year Misstatements Corrected in Current Year Financial Statements [Table Text Block]	The following table sets forth the revised prior period balances reported in our comparative financial statements:
		Previously
		reported		Adjustment		Revised
	Balance sheet items at July 31, 2014:
	Preferred Stock, Series B		2,100		260,375		262,475
	Additional paid in capital		16,777,826		-260,375		16,517,448
	Total stockholders’ equity		5,578,824		-262,475		5,316,349

Organization_and_Principal_Act2

Organization and Principal Activities (Details) (E-Care USA, Inc. [Member])	9 Months Ended
	Apr. 30, 2015
E-Care USA, Inc. [Member]
Subsidiaries Establishment And Incorporation [Line Items]
Entity Incorporation, Date of Incorporation	21-Apr-15
Entity Incorporation, State Country Name	Nevada
Relationship Subsidiary	Wholly-owned subsidiary of AmbiCom Holdings, Inc.
Sale of Stock, Nature of Operations	Designer and developer of optimizer of gaming infrastructure configuration settings.

Organization_and_Principal_Act3

Organization and Principal Activities (Details Textual) (USD $)	1 Months Ended	0 Months Ended
	29-May-14	Jan. 15, 2010	Jun. 08, 2015	Apr. 30, 2015	Jul. 31, 2014
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Initial Shares Authorized		75,000,000
Shares Authorized After Amendment of Articles of Incorporation		1,050,000,000
Common Stock, Shares Authorized			200,000,000	125,000,000	125,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)				$0.01	$0.01
Stockholders' Equity Note, Stock Split		forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	13,100,437	20,000,000
Business Combination, Options Issued to Acquire Entity Exercise Price (in dollars per share)		$0.01
Business Combination, Warrants Issued to Acquire Entity, Number of Securities Called by Warrants or Rights		500,000
Business Combination, Warrants Issued to Acquire Entity Exercise Price (in dollars per share)		$0.50
Common Stock Price Value Per Share at Closing of the Offering (in dollars per share)		$0.40
Aggregate Common Stock Shares at Closing of Offering		1,250,000
Common Stock Aggregate Offering Price Value (in dollars)		$500,000
Series A Preferred Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Preferred Stock, Shares Authorized				10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)				$0.00	$0.00
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		2,350,000
Series B Preferred Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		2,600,000
Common Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Common Stock, Shares Authorized		1,000,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)		$0.00
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		5,500,000
Preferred Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Preferred Stock, Shares Authorized		50,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)		$0.00

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross			$5,240,175
Intangible Assets, Additions			0
Intangible Assets, Gross	5,240,175		5,240,175
Accumulated Amortization			-157,800
Accumulated Amortization, Expense	-187,149	0	-561,447	0
Accumulated Amortization	-719,247		-719,247
Intangible Assets, Net			5,082,375
Intangible Assets, Net	4,520,928		4,520,928
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross			4,423,375
Intangible Assets, Additions			0
Intangible Assets, Gross	4,423,375		4,423,375
Accumulated Amortization			-133,203
Accumulated Amortization, Expense			-473,933
Accumulated Amortization	-607,136		-607,136
Intangible Assets, Net			4,290,172
Intangible Assets, Net	3,816,239		3,816,239
Weighted Average Useful Life (Years)			7 years
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross			816,800
Intangible Assets, Gross	816,800		816,800
Accumulated Amortization			-24,597
Accumulated Amortization, Expense			-87,514
Accumulated Amortization	-112,111		-112,111
Intangible Assets, Net			792,203
Intangible Assets, Net	$704,689		$704,689
Weighted Average Useful Life (Years)			7 years

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1) (USD $)	Apr. 30, 2015	Jul. 31, 2014
Finite-Lived Intangible Assets [Line Items]
2015	$187,150
2016	748,597
2017	748,597
2018	748,597
2019	748,597
Thereafter	1,339,390
Total intangible assets subject to amortization	4,520,928	5,082,375
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
2015	157,978
2016	631,911
2017	631,911
2018	631,911
2019	631,911
Thereafter	1,130,617
Total intangible assets subject to amortization	3,816,239	4,290,172
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
2015	29,172
2016	116,686
2017	116,686
2018	116,686
2019	116,686
Thereafter	208,773
Total intangible assets subject to amortization	$704,689	$792,203

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details 2) (USD $)	9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
Debt Conversion [Line Items]
Beginning Balance	$0
Issuance	439,202	0
Change in fair value recorded in other income (expense), net	139,819	0
Ending Balance	$579,021

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014
Accounting Policies [Line Items]
Allowance for Doubtful Accounts Receivable, Current (in dollars)	$270		$270		$26
Inventory allowance (in dollars)	6,856		6,856		7,352
Amortization of Intangible Assets	$187,149	$0	$561,447	$0
Vendor 1 [Member] | Cost of Goods, Total [Member]
Accounting Policies [Line Items]
Entity Wide Purchase, Major Supplier, Percentage	100.00%	97.00%	96.00%	95.00%
One Customer [Member] | Sales Revenue, Net [Member]
Accounting Policies [Line Items]
Entity Wide Revenue Major Customer Percentage			17.00%
Two Customer [Member] | Sales Revenue, Net [Member]
Accounting Policies [Line Items]
Entity Wide Revenue Major Customer Percentage		93.00%
Three Customer [Member] | Sales Revenue, Net [Member]
Accounting Policies [Line Items]
Entity Wide Revenue Major Customer Percentage				85.00%
Four Customer [Member] | Sales Revenue, Net [Member]
Accounting Policies [Line Items]
Entity Wide Revenue Major Customer Percentage	84.00%

Liquidity_and_Managements_Plan1

Liquidity and Management's Plan (Details Textual) (USD $)	3 Months Ended		9 Months Ended		1 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014	Apr. 24, 2015	21-May-15	Jul. 31, 2014	Jul. 31, 2013
Liquidity And Management Plan [Line Items]
Cash and Cash Equivalents, at Carrying Value, Total	$56,649	$249,212	$56,649	$249,212			$523,540	$596,871
Accumulated Deficit	14,150,180		14,150,180				11,420,396
Net Loss	992,759	-14,669	2,729,784	-21,230
Net Cash Used in Operating Activities			1,086,051	344,039
Debt Instrument, Face Amount	555,667		555,667
Common Stock [Member]
Liquidity And Management Plan [Line Items]
Stock Issued During Period, Shares, Other			500,000
Convertible Redeemable Note [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount					50,000
Debt Instrument, Convertible, Type of Equity Security					Common Stock at the conversion price equal to 70% of the lowest closing bid price for the 30 trading days immediately prior to conversion.
Convertible Note Agreement [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount	160,000		160,000
Convertible Debentures [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount					115,000
Debt Instrument, Interest Rate, Effective Percentage					15.00%
Proceeds from Issuance of Debt					100,000
Debt Instrument, Convertible, Type of Equity Security					the Companys Common Stock at a conversion price equal to the lesser of $0.10 or 65% of the lowest closing bid price for the 30 trading days immediately prior to conversion.
Additional Convertible Debt [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount	460,000		460,000
Debenture Agreement Effectiveness Of Registration Statement			400,000
Kodiak Capital Group LLC Investment Agreement [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount					1,000,000
Debenture Agreement Effectiveness Of Registration Statement					25,000
Kodiak Capital Group LLC Investment Agreement [Member] | Convertible Redeemable Note [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount					50,000
Equity Purchase Agreement [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount	500,000		500,000
Subsequent Event [Member] | First Convertible Note [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount						43,000
Subsequent Event [Member] | Convertible Note Agreement [Member]
Liquidity And Management Plan [Line Items]
Debt Instrument, Face Amount						$43,000
Debt Instrument, Interest Rate, Effective Percentage						8.00%
Debt Instrument, Convertible, Type of Equity Security						common stock at a conversion price equal 61% of the lowest trade price in the 10 trading days

Commitments_and_Contingencies_

Commitments and Contingencies (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014	Oct. 31, 2014
Commitments and Contingencies Disclosure [Line Items]
Rent Expenses	$13,419	$13,419	$40,256	$40,256
Capital Leased Assets, Gross	97,649		97,649		0
Capital Lease Obligations, Current	20,952		20,952		0
Capital Lease Obligations, Noncurrent	61,811		61,811		0
Lease Expiration Period			May-16
Servers And Network Switches [Member]
Commitments and Contingencies Disclosure [Line Items]
Capital Leased Assets, Gross						$93,294

Series_B_Convertible_Redeemabl1

Series B Convertible Redeemable Preferred Stock (Details Textual) (Series B Preferred Stock [Member], USD $)	9 Months Ended
	Apr. 30, 2015	Jul. 31, 2014	Sep. 30, 2011
Convertible Redeemable Preferred Stock, Series B [Line Items]
Preferred Stock, Shares Outstanding	262,475	262,475
Preferred Stock, Dividend Rate, Percentage	6.00%
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$1
Stock Conversion Price	$0.40
Weighted Average Price of Common Stock Percentage	70.00%
Preferred Stock, Redemption Price Per Share	$1
Preferred Stock, Liquidation Preference, Value	$2,600,000
Before Amendment [Member]
Convertible Redeemable Preferred Stock, Series B [Line Items]
Preferred Stock, Shares Authorized			2,600,000
Preferred Stock, Par or Stated Value Per Share			$0.00
After Amendment [Member]
Convertible Redeemable Preferred Stock, Series B [Line Items]
Preferred Stock, Shares Authorized			325,000
Preferred Stock, Par or Stated Value Per Share			$0.01

Shareholders_Equity_Details_Te

Shareholders' Equity (Details Textual) (USD $)	9 Months Ended		1 Months Ended			0 Months Ended	1 Months Ended		0 Months Ended	1 Months Ended				3 Months Ended	0 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 21, 2015	Nov. 04, 2014	Oct. 22, 2014	Oct. 03, 2014	Oct. 13, 2014	Sep. 23, 2014	12-May-14	27-May-14	Mar. 25, 2014	Oct. 31, 2011	Apr. 24, 2015	Apr. 30, 2015	Aug. 11, 2014	Sep. 05, 2014	Jun. 08, 2015	Jul. 31, 2014	Sep. 30, 2011
Stockholders' Equity Note [Line Items]
Common Stock, Shares, Issued	50,448,682													50,448,682				26,162,093
Common Stock, Shares, Outstanding	50,448,682													50,448,682				26,162,093
Common Stock, Par or Stated Value Per Share (in dollars per share)	$0.01													$0.01				$0.01
Share-based Compensation (in dollars)	$195,024	$9,818
Proceeds from Issuance of Common Stock	145,000	25,000
Common Stock, Shares Authorized	125,000,000													125,000,000			200,000,000	125,000,000
Issuance Of Stock To Investor As A Commitment Fee	95,000	0
Stock or Unit Option Plan Expense	4,780	0
Kodiak Capital Group LLC Investment Agreement [Member]
Stockholders' Equity Note [Line Items]
Maximum Value Of Common Stock To Be Purchased			1,000,000									1,000,000
Common Stock Purchase Price Volume Percentage			80.00%									80.00%
Proceeds from Issuance of Common Stock			25,000									25,000
Stock Issued During Period, Shares, New Issues	500,000			215,518	223,215	168,919	219,491	148,810	208,333	100,806	120,193
Stock Issued During Period, Value, New Issues	25,000								25,000			25,000
Issuance Of Stock To Investor As A Commitment Fee	95,000
Agreement with investor [Member]
Stockholders' Equity Note [Line Items]
Stock Issued During Period, Shares, New Issues													500,000
Stock Issued During Period, Value, New Issues													25,000
Equity Incentive Plan 2010 [Member]
Stockholders' Equity Note [Line Items]
Stock or Unit Option Plan Expense	92,125													30,477
Employee and Consultant [Member]
Stockholders' Equity Note [Line Items]
Stock Issued During Period, Shares, New Issues	236,758
Common Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred Stock, Shares Authorized	20,000,000													20,000,000
Common Stock, Shares, Outstanding	50,448,682													50,448,682				26,162,093
Stock Issued During Period, Shares, Issued for Services	15,760
Conversion of Stock, Shares Converted	20,000,000
Common Stock [Member] | Convertible Debt [Member]
Stockholders' Equity Note [Line Items]
Stock Issued During Period, Shares, Issued for Services	500,000
Common Stock [Member] | Primary Note [Member]
Stockholders' Equity Note [Line Items]
Stock Issued During Period, Shares, Issued for Services	200,000
Common Stock [Member] | Service Providers [Member]
Stockholders' Equity Note [Line Items]
Stock Issued During Period, Shares, Issued for Services	1,858,118
Common Stock [Member] | Kodiak Capital Group LLC Investment Agreement [Member]
Stockholders' Equity Note [Line Items]
Stock Issued During Period, Shares, Issued for Services	1,475,953
Common Stock [Member] | Before Amendment [Member]
Stockholders' Equity Note [Line Items]
Common Stock, Shares, Issued																			1,000,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)																			$0.00
Common Stock [Member] | After Amendment [Member]
Stockholders' Equity Note [Line Items]
Common Stock, Shares, Issued																			125,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)																			$0.01
Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred Stock, Shares Authorized	50,000,000													50,000,000
Series A Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred Stock, Shares Authorized	10,000,000													10,000,000				10,000,000
Conversion of Stock, Shares Converted	10,000,000
Series B Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred Stock, Dividend Rate, Percentage	6.00%
Equity Incentive Plans 2010 [Member]
Stockholders' Equity Note [Line Items]
Exercise Price of Options, Description	the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	477,778
Equity Incentive Plans 2010 [Member] | Common Stock Issuance One [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	200,000													200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.20													$0.20
Equity Incentive Plans 2010 [Member] | Common Stock Issuance Two [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	250,000													250,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.09													$0.09
Equity Incentive Plans 2010 [Member] | Common Stock Issuance Three [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	75,000													75,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.03													$0.03
Equity Incentive Plans 2010 [Member] | Common Stock Issuance Four [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	275,000													275,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.16													$0.16
Equity Incentive Plans 2010 [Member] | Common Stock Issuance Five [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	1,000,000													1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.24													$0.24
Equity Incentive Plans 2010 [Member] | Common Stock [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	1,800,000													1,800,000
Series A Convertible Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Conversion of Stock, Shares Converted	10,000,000
Equity Incentive Plans 2014 [Member]
Stockholders' Equity Note [Line Items]
Common Stock, Shares, Issued	10,000,000													10,000,000
Exercise Price of Options, Description	the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	2,500,000													2,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.24													$0.24
Equity Incentive Plans 2014 [Member] | Two Employees [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross															1,750,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price															$0.24
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate															2.48%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate															49.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term															6 years 6 months
Share-based Compensation (in dollars)	81,387													27,129
Equity Incentive Plans 2014 [Member] | One Employee [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																750,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price																$0.24
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate																2.48%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate																43.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term																6 years 6 months
Share-based Compensation (in dollars)	$21,512													$8,067
Equity Incentive Plans 2014 [Member] | Common Stock [Member]
Stockholders' Equity Note [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	2,500,000													2,500,000

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Apr. 30, 2015	Jul. 31, 2014
Property, Plant and Equipment [Line Items]
Furniture and fixture	$27,634	$27,634
Machinery and equipment	125,190	27,540
Software	359,417	359,417
Leasehold Improvements	5,985	5,985
Vehicle	105,278	105,278
Property, Plant and Equipment, Gross	623,504	525,854
Accumulated depreciation	-457,161	-428,291
Property and equipment, net	$166,343	$97,563

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014
Property, Plant and Equipment [Line Items]
Depreciation	$11,054	$6,488	$28,870	$17,675
Capital Leased Assets, Gross	97,649		97,649		0
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation	$9,914		$9,914		$0
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives			seven years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives			five years
Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives			five years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives			the life of the current facility lease

Note_Payable_Auto_loan_Details

Note Payable (Auto loan) (Details) (USD $)	Apr. 30, 2015	Jul. 31, 2014
Notes Payable Unsecured Disclosure [Line Items]
Note payable (Auto Loan)	$64,759	$74,713
Less current portion	15,688	15,735
Long-term note payable	$49,071	$58,978

Note_Payable_Auto_loan_Details1

Note Payable (Auto loan) (Details Textual) (Secured Debt [Member], Notes Payable, Other Payables [Member])	9 Months Ended
	Apr. 30, 2015
Secured Debt [Member] | Notes Payable, Other Payables [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	3.99%
Debt Instrument, Maturity Date	9-Oct-19

Convertible_Debt_and_Derivativ2

Convertible Debt and Derivative Liability (Details) (USD $)	Apr. 30, 2015
Principal balance	$555,667
Debt discount	-473,705
Net carrying value of debt	81,962
Less current portion	56,406
Long-term net carrying value of debt	$25,556

Convertible_Debt_and_Derivativ3

Convertible Debt and Derivative Liability (Details Textual) (USD $)	9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 24, 2015
Debt Instrument, Face Amount	$555,667
Debt Instrument, Unamortized Discount	473,705
Increase (Decrease) in Derivative Liabilities	139,819	0
Amortization of Debt Discount (Premium)	47,581
Convertible Note Agreement [Member]
Debt Instrument, Face Amount	160,000
Stock Issued During Period, Shares, Share-based Compensation, Gross	200,000
Debt Instrument, Unamortized Discount	102,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	70.00%
Derivative Liability, Fair Value, Gross Liability	191,122
Increase (Decrease) in Derivative Liabilities	89,122
Debt Instrument, Convertible, Remaining Discount Amortization Period	3 years
Debt Instrument, Convertible, Threshold Trading Days	20
Debt Instrument, Term	3 years
Amortization of Debt Discount (Premium)	42,000
Debt, Long-term and Short-term, Combined Amount	285,000
Convertible Note Agreement One [Member]
Debt Instrument, Unamortized Discount	60,667
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	60.00%
Derivative Liability, Fair Value, Gross Liability	80,355
Increase (Decrease) in Derivative Liabilities	20,355
Debt Instrument, Convertible, Remaining Discount Amortization Period	2 years
Debt Instrument, Convertible, Threshold Trading Days	25
Debt Instrument, Term	2 years
Debt, Long-term and Short-term, Combined Amount	66,667
Debt Instrument, Convertible, Conversion Price	$0.15
Debt Instrument Convertible Conditional Trading Days	90
Debt Instrument One Time Interest Fee Percentage	12.00%
Convertible Note Agreement Two [Member]
Debt Instrument, Unamortized Discount	89,672
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	60.00%
Derivative Liability, Fair Value, Gross Liability	86,562
Increase (Decrease) in Derivative Liabilities	3,110
Debt Instrument, Convertible, Remaining Discount Amortization Period	1 year
Debt Instrument, Convertible, Threshold Trading Days	15
Debt Instrument, Term	1 year
Debt, Long-term and Short-term, Combined Amount	100,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Convertible Note Agreement Three [Member]
Debt Instrument, Unamortized Discount	60,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	61.00%
Derivative Liability, Fair Value, Gross Liability	54,619
Increase (Decrease) in Derivative Liabilities	1,339
Debt Instrument, Convertible, Remaining Discount Amortization Period	1 year
Debt Instrument, Convertible, Threshold Trading Days	10
Debt Instrument, Term	1 year
Debt, Long-term and Short-term, Combined Amount	64,000
Debt Instrument Convertible Conditional Trading Days	180
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Convertible Note Agreement Four [Member]
Debt Instrument, Face Amount	115,000
Debt Instrument, Unamortized Discount	100,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	65.00%
Derivative Liability, Fair Value, Gross Liability	135,388
Increase (Decrease) in Derivative Liabilities	35,388
Debt Instrument, Convertible, Remaining Discount Amortization Period	1 year
Debt Instrument, Convertible, Threshold Trading Days	30
Debt Instrument, Term	1 year
Debt, Long-term and Short-term, Combined Amount	115,000
Debt Instrument, Convertible, Conversion Price	$0.10
Debt Instrument, Interest Rate, Stated Percentage	15.00%
Convertible Note Agreement Five [Member]
Debt Instrument, Unamortized Discount	31,572
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	70.00%
Derivative Liability, Fair Value, Gross Liability	30,975
Increase (Decrease) in Derivative Liabilities	597
Debt Instrument, Convertible, Remaining Discount Amortization Period	7 months
Debt Instrument, Convertible, Threshold Trading Days	30
Debt Instrument, Term	8 months
Debt, Long-term and Short-term, Combined Amount	50,000
Debt Instrument, Interest Rate, Stated Percentage	1.00%
Convertible Debentures [Member]
Debt Instrument, Face Amount			$115,000

Revision_of_Prior_Period_Amoun2

Revision of Prior Period Amounts (Details) (USD $)	Apr. 30, 2015	Jul. 31, 2014
Preferred Stock, Series B	$262,475	$262,475
Additional paid in capital	17,137,061	16,517,448
Total stockholders' equity	3,390,468	5,316,349
Scenario, Previously Reported [Member]
Additional paid in capital		16,777,826
Total stockholders' equity		5,578,824
Restatement Adjustment [Member]
Additional paid in capital		-260,375
Total stockholders' equity		-262,475
Redeemable Convertible Preferred Stock [Member]
Preferred Stock, Series B		262,475
Redeemable Convertible Preferred Stock [Member] | Scenario, Previously Reported [Member]
Preferred Stock, Series B		2,100
Redeemable Convertible Preferred Stock [Member] | Restatement Adjustment [Member]
Preferred Stock, Series B		$260,375

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)	1 Months Ended
	Apr. 24, 2015	21-May-15	Jun. 08, 2015	Apr. 30, 2015	Jul. 31, 2014
Subsequent Event [Line Items]
Debt Instrument, Face Amount				$555,667
Common Stock, Shares Authorized			200,000,000	125,000,000	125,000,000
Common Stock, Par or Stated Value Per Share				$0.01	$0.01
Convertible Note Agreement [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount				160,000
Convertible Debentures [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	115,000
Debt Instrument, Interest Rate, Effective Percentage	15.00%
Debt Instrument, Convertible, Type of Equity Security	the Companys Common Stock at a conversion price equal to the lesser of $0.10 or 65% of the lowest closing bid price for the 30 trading days immediately prior to conversion.
Common Stock [Member]
Subsequent Event [Line Items]
Preferred Stock, Shares Authorized				20,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Capital Units, Authorized			250,000,000
Common Stock, Shares Authorized			200,000,000
Common Stock, Par or Stated Value Per Share			0.008
Preferred Stock, Shares Authorized			50,000,000
Preferred Stock, Par or Stated Value Per Share			0.001
Subsequent Event [Member] | Convertible Note Agreement [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount		$43,000
Debt Instrument, Interest Rate, Effective Percentage		8.00%
Debt Instrument, Convertible, Type of Equity Security		common stock at a conversion price equal 61% of the lowest trade price in the 10 trading days
Debt Instrument, Maturity Date		26-Feb-16